Date | Time | Source | Headline | Symbol | Company |
05/04/2011 | 01:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:28 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
05/04/2011 | 01:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
01/04/2011 | 19:30 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
30/03/2011 | 10:30 | Zacks | Onyx Modifies Carfilzomib EU Trial - Analyst Blog | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/03/2011 | 16:19 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/03/2011 | 16:18 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/03/2011 | 16:18 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
29/03/2011 | 03:00 | PR Newswire (US) | Onyx Pharmaceuticals Announces Plans to Amend Phase 3 FOCUS Study for European Registration | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
11/03/2011 | 21:00 | PR Newswire (US) | Onyx Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
02/03/2011 | 21:00 | PR Newswire (US) | Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
28/02/2011 | 13:00 | PR Newswire (US) | S*BIO's Novel Dual mTOR/PI3 Kinase Inhibitor SB2343 Demonstrates Excellent PK/PD Properties Leading to Significant Anti-Tumor Ef | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
24/02/2011 | 08:00 | PR Newswire (US) | Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients Wit | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
23/02/2011 | 21:44 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
23/02/2011 | 21:21 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
23/02/2011 | 21:00 | PR Newswire (US) | Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
15/02/2011 | 21:00 | PR Newswire (US) | Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results Teleconference and Webcast | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
14/02/2011 | 23:17 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
14/02/2011 | 18:55 | Edgar (US Regulatory) | Schedule 13G | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
11/02/2011 | 14:52 | PR Newswire (US) | Zacks Bull and Bear of the Day Highlights: Brightpoint, Onyx Pharmaceuticals, Wal-Mart, Family Dollar and Kroger's | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
09/02/2011 | 16:03 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
08/02/2011 | 15:23 | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
08/02/2011 | 00:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |
08/02/2011 | 00:19 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONXX | Onyx Pharmaceuticals, Inc. (MM) |